Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease states

US7534903B2 · kind B2 · utility

Assignee

• Solvay Pharmaceuticals, GmbH · US

Inventors

• David Sykes · Boston, US
• Brian Moloney · Biggenden, AU
• Lester Marrison · Biggenden, AU
• Dieter Ziegler · Hemmingen, DE
• Michael Mlinaric · Hannover, DE
• Christiane Boecker · Hannover, DE
• Reinhard Brueckner · Hannover, DE
• Michael Weske · Burgdorf, DE
• Klaus Witte · Hannover, DE
• Yvan Fischer · Barsinghausen, DE

Key dates

• Filing date: Jan 18, 2008
• Grant date: May 19, 2009
• Expiry date: Jan 18, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D311/68
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The use of compounds corresponding to formula I:in which R1, R2, R3, R4, R5 and R6 have the meanings given in the description for treating cardiac arrhythmias and other disease states.